NEW YORK, NY — (Marketwired) — 11/05/13 — (NASDAQ: OXBT) is developing medical products that efficiently deliver oxygen to tissues in the body. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte® that is currently in clinical and preclinical studies for intravenous delivery for indications such as traumatic brain injury, decompression sickness and stroke. The company is also developing PFC-based creams and gels for topical delivery to
NEW YORK, NY — (Marketwired) — 08/27/13 — (PINKSHEETS: PGCX) pursues business opportunities in fiberglass recycling and marketing manufactured products made from recycled fiberglass fibers, other fibers and virgin materials.(OTCQB: AHRO) is an early stage biotech company focused on novel compounds to reduce or regress atherosclerotic plaque deposits. The Company-s focus on compounds to reduce or eliminate atherosclerotic plaque deposits and addresses the most lucrative segments of the multi-
NEW YORK, NY — (Marketwired) — 07/01/13 –(PINKSHEETS: EPOR) through its subsidiary, RXHealthcaresystems, enters into agreements with companies developing technology for healthcare products. The essence of these agreements is to aid the companies with product commercialization, product procurement, marketing and distribution. Then once a product receives regulatory approval, if needed, and can be sold, EPOR becomes the financial manager of a joint venture, directly or indirectly, with the rese
